Chlamydia RNA Test

Chlamydia is the most frequently reported bacterial sexually transmitted infection, and the majority of people who have it feel perfectly fine. There are no sores, no obvious discharge, no fever. That silence is exactly what makes it dangerous: left undetected, the infection can spread deeper into your reproductive tract over weeks to months and cause damage that is difficult or impossible to reverse.

This test detects the genetic material (RNA) of Chlamydia trachomatis, the bacterium responsible for the infection. Because it looks for the organism's RNA directly rather than waiting for your immune system to produce antibodies, it can identify an active infection earlier and more accurately than older testing methods. A simple urine sample is all that is needed.

Why a Silent Infection Matters

The reason chlamydia screening exists is that the infection causes its worst harm while you feel nothing. In women, untreated chlamydia can travel from the cervix into the uterus and fallopian tubes, triggering pelvic inflammatory disease (PID), a condition where inflammation and scarring can block the tubes and lead to infertility or life-threatening ectopic pregnancy, where a fertilized egg implants outside the uterus.

In men, the infection can spread to the tube that carries sperm from the testicle (the epididymis), causing pain, swelling, and in some cases reduced fertility. For both sexes, an active chlamydia infection also makes it easier to acquire or transmit other sexually transmitted infections, including HIV.

Pregnant women with untreated chlamydia can pass the infection to their newborn during delivery, potentially causing eye infections or pneumonia in the baby. Screening during pregnancy is standard practice for this reason.

How RNA Testing Works

This test uses a technology called nucleic acid amplification testing (NAAT). In plain terms, the lab takes a tiny amount of genetic material from your urine sample and copies it millions of times. If even a small amount of Chlamydia trachomatis RNA is present, this amplification process makes it detectable. NAAT is considered the gold standard for chlamydia detection because it is both highly sensitive (it catches almost all true infections) and highly specific (it rarely flags someone who is not infected).

Unlike blood-based antibody tests, which can remain positive long after an infection has cleared, RNA detection tells you whether the bacterium is actively present right now. This makes it the right test both for initial screening and for confirming that treatment has worked.

Who Should Be Screened

Major health organizations recommend annual chlamydia screening for all sexually active women under 25, because this age group carries the highest infection rates and the greatest risk of fertility-damaging complications. Women 25 and older should be screened annually if they have a new sexual partner, multiple partners, or a partner with a known STI.

Men who have sex with men should be screened at least annually, and more frequently (every three to six months) if they have multiple partners. Heterosexual men are not routinely screened by most guidelines, but if you have a new partner or symptoms like burning with urination or unusual discharge, testing is straightforward and worth doing.

If you are pregnant or planning to become pregnant, screening at the first prenatal visit is standard. A second test in the third trimester is recommended if you are under 25 or have risk factors.

Understanding Your Result

Your result will come back as either "detected" (positive) or "not detected" (negative). There is no gray zone or borderline reading with this test.

• Detected (positive): Chlamydia trachomatis RNA was found in your sample. You have an active infection and should begin treatment promptly. Your recent sexual partners (generally anyone within the past 60 days) should also be tested and treated.
• Not detected (negative): No chlamydia RNA was found. If you were tested within the correct window (at least one to two weeks after potential exposure), a negative result reliably rules out current infection.

A positive result is not a reason to panic. Chlamydia is one of the most treatable infections in medicine. A short course of antibiotics prescribed by a clinician clears the infection in the vast majority of cases. The key is catching it before it has time to cause structural damage.

When Results Can Be Misleading

False negatives are rare with NAAT, but they can happen if you test too soon after exposure. The bacterium needs roughly five to fourteen days after transmission to produce enough RNA for the test to detect. If you had a possible exposure within the past two weeks and test negative, consider retesting after the window period has passed.

Contamination of the urine sample is uncommon but possible. To get the most accurate result, collect the first part of your urine stream (not midstream) and avoid urinating for at least one to two hours before sample collection. This allows enough bacterial material to accumulate in the urethra.

Tracking Over Time

Unlike a cholesterol number or a blood sugar level, chlamydia RNA is not a marker you trend on a graph. But the principle of repeat testing still applies. A single negative result tells you about right now. It does not protect you from future exposure. If your risk factors persist (new partners, inconsistent barrier protection), annual retesting is the minimum. Every three to six months is better if your risk is higher.

After treatment for a positive result, a test of cure at three to four weeks confirms the infection is gone, and a repeat screen at three months catches reinfection early. Think of screening not as a one-time event but as a recurring part of your sexual health maintenance, no different from an annual physical or a dental cleaning.